U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07554573) titled 'Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post Lumpectomy (ABCD RT)' on April 21.
Brief Summary: NRG-CC016 is being done to determine if omission of radiation therapy (RT) for patients with biosignature Low Risk (DCISionRT score less than 2.8) DCIS yields no clinically meaningful increase ipsilateral breast recurrence (IBR) compared to those treated with RT (Cohort A).
Study Start Date: June 30
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervention:
RADIATION: Radiation Therapy
Post-lumpectomy RT will be external beam radiation to the whole breast ± boost (sequential or integra...